Company Filing History:
Years Active: 2021
Title: The Innovative Contributions of Shumin Yi in Phage Technology
Introduction
Shumin Yi is a notable inventor based in Jinzhou, China. He holds a patent for a unique virulent phage, which is an important innovation in the field of phage therapy. This technological advancement has the potential to revolutionize how bacterial infections are treated, emphasizing the significance of his contributions to science and medicine.
Latest Patents
Shumin Yi's patent primarily revolves around the virulent phage φPf1901 and its preparation and application. The patent, focusing on the technical field of phage, reveals that this virulent phage has an accession number of CCTCC M2019447. The virulent phage φPf1901 boasts a titer of (1.4-3) × 10 PFU/mL, indicating its robust lytic ability. Additionally, it has been identified with an optimal multiplicity of infection (MOI) value of 0.0001, showcasing its high specificity and capability to effectively control bacterial populations. This innovation is positioned to demonstrate strong lytic and scavenging effects on its host.
Career Highlights
Shumin Yi is associated with Bohai University, where he contributes his expertise and knowledge in phage technology. Throughout his career, he has made significant strides in research, focusing on the potential applications of phage in combating antibiotic-resistant bacteria. His work underscores the vital intersection of innovation and practical applications in medical sciences.
Collaborations
In his pursuit of innovation, Shumin Yi collaborates with esteemed colleagues such as Jianrong Li and Defu Zhang. These relationships foster a creative and resourceful research environment, enhancing the development of novel solutions in the field of phage therapy.
Conclusion
Shumin Yi's innovative work on the virulent phage φPf1901 marks a pivotal advancement in phage technology. His commitment to exploring and expanding the applications of phages reflects his status as a leading inventor in this critical area of research. The implications of his patent are poised to significantly impact the future of bacterial infection management and highlight the essential role of inventors in addressing global health challenges.